Thursday, March 14, 2019

Zacks Investment Research Lowers Global Medical REIT (GMRE) to Hold

Global Medical REIT (NYSE:GMRE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

Get Global Medical REIT alerts:

Several other research analysts have also commented on GMRE. B. Riley set a $11.00 price target on Global Medical REIT and gave the stock a “buy” rating in a report on Friday. Boenning Scattergood reiterated a “buy” rating on shares of Global Medical REIT in a report on Thursday, March 7th. Finally, Janney Montgomery Scott lowered shares of Global Medical REIT from a “buy” rating to a “neutral” rating and set a $9.03 target price on the stock. in a report on Wednesday, December 19th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $10.17.

GMRE traded up $0.09 during trading on Tuesday, hitting $10.42. 771,191 shares of the stock traded hands, compared to its average volume of 157,750. The company has a debt-to-equity ratio of 1.66, a current ratio of 0.09 and a quick ratio of 0.09. Global Medical REIT has a twelve month low of $6.34 and a twelve month high of $10.76. The company has a market cap of $234.97 million, a P/E ratio of 19.30, a P/E/G ratio of 1.32 and a beta of 0.58.

In other news, major shareholder Zh Usa, Llc acquired 1,111,111 shares of the firm’s stock in a transaction on Friday, December 14th. The shares were purchased at an average price of $9.00 per share, for a total transaction of $9,999,999.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 13.00% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of GMRE. D. E. Shaw & Co. Inc. bought a new stake in shares of Global Medical REIT in the fourth quarter valued at approximately $89,000. Bank of America Corp DE increased its stake in shares of Global Medical REIT by 113.3% during the fourth quarter. Bank of America Corp DE now owns 10,296 shares of the company’s stock worth $92,000 after buying an additional 5,470 shares during the period. Schnieders Capital Management LLC acquired a new position in shares of Global Medical REIT in the 4th quarter valued at approximately $116,000. Squarepoint Ops LLC bought a new position in Global Medical REIT during the fourth quarter worth about $118,000. Finally, State Board of Administration of Florida Retirement System increased its position in Global Medical REIT by 10.5% during the 4th quarter. State Board of Administration of Florida Retirement System now owns 15,526 shares of the company’s stock valued at $138,000 after purchasing an additional 1,474 shares during the period. 42.36% of the stock is currently owned by institutional investors.

Global Medical REIT Company Profile

Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

See Also: What are the advantages of the Stochastic Momentum Index?

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Global Medical REIT (NYSE:GMRE)

No comments:

Post a Comment